LBA11504 Randomized Phase II Trial of Cabozantinib Combined with PD-1 and CTLA-4 Inhibition Versus Cabozantinib in Metastatic Soft Tissue Sarcoma.

Vanessa Eulo, Jacqui Toeniskoetter,Tyler Ruff,Jingqin Luo, Lindsey Kemp,Cristiam Moreno Tellez,Mia C. Weiss,Angela C. Hirbe,Christian Frederick Meyer,Anthony D. Elias,Mark Diamond,Lee P. Hartner,Nam Bui,Kristen N. Ganjoo,Robert G. Maki,Breelyn A. Wilky

JOURNAL OF CLINICAL ONCOLOGY（2023）

Cited 4|Views16

Key words

283-166-2415,283-166-205,613-135-2370-5109,298-145-222,613-135-244-3829-325,613-3267-5166-9204-5168,613-7657-304,171,3581,171,38092-29187,38092-21186,38116-38094-8

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined